Building blocks
Heterocyclic, chiral, fluorinated and coupling-ready records for medicinal chemistry programs.
R&D and route-development sourcing
A sourcing route for pharmaceutical R&D teams, laboratories and manufacturers working from target structures, CAS lists and route-specific intermediate requirements.
01 / Requirement
A discovery-stage request and a manufacturing-stage requirement need different evidence, scale assumptions and supplier questions.
Heterocyclic, chiral, fluorinated and coupling-ready records for medicinal chemistry programs.
Route-specific molecules reviewed against target purity, scale and expected timing.
Potential starting materials and advanced intermediates evaluated for a larger commercial requirement.
API sourcing handled through specification, intended market and documentation-led qualification.
02 / API raw materials
Human and veterinary APIs are handled as specification-led commercial requests, separate from the synthesis-on-demand intermediate catalog. Product identity, pharmacopoeial or customer specification, manufacturing source, intended market, quantity and documentation expectations are reviewed before a quotation is prepared.
03 / Campaign core
These records are publication priorities, not stock claims. Availability and commercial feasibility are confirmed against the actual request.
04 / Inquiry
For APIs, also include intended market, standard or specification and required documentation. For intermediates, a CAS list or structure-led requirement is sufficient to begin matching.